These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11472221)

  • 1. (-)3-[4-[2-(Phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic acid [(-)DRF 2725]: a dual PPAR agonist with potent antihyperglycemic and lipid modulating activity.
    Lohray BB; Lohray VB; Bajji AC; Kalchar S; Poondra RR; Padakanti S; Chakrabarti R; Vikramadithyan RK; Misra P; Juluri S; Mamidi NV; Rajagopalan R
    J Med Chem; 2001 Aug; 44(16):2675-8. PubMed ID: 11472221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of alpha-aryloxy-alpha-methylhydrocinnamic acids: a novel class of dual peroxisome proliferator-activated receptor alpha/gamma agonists.
    Xu Y; Rito CJ; Etgen GJ; Ardecky RJ; Bean JS; Bensch WR; Bosley JR; Broderick CL; Brooks DA; Dominianni SJ; Hahn PJ; Liu S; Mais DE; Montrose-Rafizadeh C; Ogilvie KM; Oldham BA; Peters M; Rungta DK; Shuker AJ; Stephenson GA; Tripp AE; Wilson SB; Winneroski LL; Zink R; Kauffman RF; McCarthy JR
    J Med Chem; 2004 May; 47(10):2422-5. PubMed ID: 15115385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel tricyclic-alpha-alkyloxyphenylpropionic acids: dual PPARalpha/gamma agonists with hypolipidemic and antidiabetic activity.
    Sauerberg P; Pettersson I; Jeppesen L; Bury PS; Mogensen JP; Wassermann K; Brand CL; Sturis J; Wöldike HF; Fleckner J; Andersen AS; Mortensen SB; Svensson LA; Rasmussen HB; Lehmann SV; Polivka Z; Sindelar K; Panajotova V; Ynddal L; Wulff EM
    J Med Chem; 2002 Feb; 45(4):789-804. PubMed ID: 11831892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ragaglitazar: a novel PPAR alpha PPAR gamma agonist with potent lipid-lowering and insulin-sensitizing efficacy in animal models.
    Chakrabarti R; Vikramadithyan RK; Misra P; Hiriyan J; Raichur S; Damarla RK; Gershome C; Suresh J; Rajagopalan R
    Br J Pharmacol; 2003 Oct; 140(3):527-37. PubMed ID: 12970088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological and structural characterization of the dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist ragaglitazar.
    Ebdrup S; Pettersson I; Rasmussen HB; Deussen HJ; Frost Jensen A; Mortensen SB; Fleckner J; Pridal L; Nygaard L; Sauerberg P
    J Med Chem; 2003 Apr; 46(8):1306-17. PubMed ID: 12672231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of oxime ethers of alpha-acyl-beta-phenylpropanoic acids as PPAR dual agonists.
    Oon Han H; Kim SH; Kim KH; Hur GC; Joo Yim H; Chung HK; Ho Woo S; Dong Koo K; Lee CS; Sung Koh J; Kim GT
    Bioorg Med Chem Lett; 2007 Feb; 17(4):937-41. PubMed ID: 17157019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationship studies of cinnamic acid-based novel thiazolidinedione antihyperglycemic agents.
    Neogi P; Lakner FJ; Medicherla S; Cheng J; Dey D; Gowri M; Nag B; Sharma SD; Pickford LB; Gross C
    Bioorg Med Chem; 2003 Sep; 11(18):4059-67. PubMed ID: 12927868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel thieno oxazine analogues as antihyperglycemic and lipid modulating agents.
    Das SK; Reddy KA; Abbineni C; Iqbal J; Suresh J; Premkumar M; Chakrabarti R
    Bioorg Med Chem Lett; 2003 Feb; 13(3):399-403. PubMed ID: 12565938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of 2-methyl-2-[4-(2-[5-methyl-2-aryloxazol-4-yl]ethoxy)phenoxy]propionic acids: a new class of dual PPARalpha/gamma agonists.
    Brooks DA; Etgen GJ; Rito CJ; Shuker AJ; Dominianni SJ; Warshawsky AM; Ardecky R; Paterniti JR; Tyhonas J; Karanewsky DS; Kauffman RF; Broderick CL; Oldham BA; Montrose-Rafizadeh C; Winneroski LL; Faul MM; McCarthy JR
    J Med Chem; 2001 Jun; 44(13):2061-4. PubMed ID: 11405642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DRF 2655: a unique molecule that reduces body weight and ameliorates metabolic abnormalities.
    Vikramadithyan RK; Hiriyan J; Suresh J; Gershome C; Babu RK; Misra P; Rajagopalan R; Chakrabarti R
    Obes Res; 2003 Feb; 11(2):292-303. PubMed ID: 12582227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and anti-diabetic activity of (RS)-2-ethoxy-3-{4-[2-(4-trifluoro-methanesulfonyloxy-phenyl)-ethoxy]-phenyl}-propionic acid.
    Cai ZF; Liu Q; Li PP; Guo ZR; Shen ZF
    Acta Pharmacol Sin; 2006 May; 27(5):597-602. PubMed ID: 16626515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylacetic acid derivatives as hPPAR agonists.
    Santini C; Berger GD; Han W; Mosley R; MacNaul K; Berger J; Doebber T; Wu M; Moller DE; Tolman RL; Sahoo SP
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1277-80. PubMed ID: 12657263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel phthalazinone and benzoxazinone containing thiazolidinediones as antidiabetic and hypolipidemic agents.
    Madhavan GR; Chakrabarti R; Kumar SK; Misra P; Mamidi RN; Balraju V; Kasiram K; Babu RK; Suresh J; Lohray BB; Lohrayb VB; Iqbal J; Rajagopalan R
    Eur J Med Chem; 2001; 36(7-8):627-37. PubMed ID: 11600232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidiabetic and hypolipidemic potential of DRF 2519--a dual activator of PPAR-alpha and PPAR-gamma.
    Chakrabarti R; Misra P; Vikramadithyan RK; Premkumar M; Hiriyan J; Datla SR; Damarla RK; Suresh J; Rajagopalan R
    Eur J Pharmacol; 2004 May; 491(2-3):195-206. PubMed ID: 15140637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ragaglitazar: the pharmacokinetics, pharmacodynamics, and tolerability of a novel dual PPAR alpha and gamma agonist in healthy subjects and patients with type 2 diabetes.
    Skrumsager BK; Nielsen KK; Müller M; Pabst G; Drake PG; Edsberg B
    J Clin Pharmacol; 2003 Nov; 43(11):1244-56. PubMed ID: 14551179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosiglitazone treatment improves insulin regulation and dyslipidemia in type 2 diabetic cynomolgus monkeys.
    Gee MK; Zhang L; Rankin SE; Collins JN; Kauffman RF; Wagner JD
    Metabolism; 2004 Sep; 53(9):1121-5. PubMed ID: 15334371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical models.
    Etgen GJ; Oldham BA; Johnson WT; Broderick CL; Montrose CR; Brozinick JT; Misener EA; Bean JS; Bensch WR; Brooks DA; Shuker AJ; Rito CJ; McCarthy JR; Ardecky RJ; Tyhonas JS; Dana SL; Bilakovics JM; Paterniti JR; Ogilvie KM; Liu S; Kauffman RF
    Diabetes; 2002 Apr; 51(4):1083-7. PubMed ID: 11916929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological activity of potent and orally available G protein-coupled receptor 40 agonists.
    Sasaki S; Kitamura S; Negoro N; Suzuki M; Tsujihata Y; Suzuki N; Santou T; Kanzaki N; Harada M; Tanaka Y; Kobayashi M; Tada N; Funami M; Tanaka T; Yamamoto Y; Fukatsu K; Yasuma T; Momose Y
    J Med Chem; 2011 Mar; 54(5):1365-78. PubMed ID: 21319751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of dual peroxisome proliferator-activated receptors gamma and delta agonists as novel euglycemic agents with a reduced weight gain profile.
    Xu Y; Etgen GJ; Broderick CL; Canada E; Gonzalez I; Lamar J; Montrose-Rafizadeh C; Oldham BA; Osborne JJ; Xie C; Shi Q; Winneroski LL; York J; Yumibe N; Zink R; Mantlo N
    J Med Chem; 2006 Sep; 49(19):5649-52. PubMed ID: 16970391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Aryl thiazolidine-2,4-diones as selective PPARgamma agonists.
    Koyama H; Boueres JK; Han W; Metzger EJ; Bergman JP; Gratale DF; Miller DJ; Tolman RL; MacNaul KL; Berger JP; Doebber TW; Leung K; Moller DE; Heck JV; Sahoo SP
    Bioorg Med Chem Lett; 2003 May; 13(10):1801-4. PubMed ID: 12729668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.